Bio-Path Holdings Inc (NASDAQ:BPTH) I've covered this low floater in the past, and it appears the stock is getting attention again. I've always felt this stock has potential to rally. From a technical standpoint, it needs to break through $6.20 to really get going. A break of that figure brings $7.80 into focus. Keep a close eye on this one the next few days.
Is it time for this beast to reawaken? May 29th we will find out!
BPTH, the ticker to the company Bio Path Holdings is currently trending down. This ticker has been a poor performer for the entire year with small time periods where day traders may make an easy 20-60 percent. Bio Path may seem like a decent day trading target where it follows the downward trending line and tends to bounce up a few days after coming into contact...
Bio-Path released updated Phase 2 data for its lead candidate prexigebersen, codenamed BP1001, for treating acute myeloid leukemia, or AML, and also divulged a plan of action for taking the compound through clinical development toward registration. Updated data from the Stage 1 of the Phase 2 study that evaluated the efficacy and safety of prexigebersen in...